The global vitamins, minerals, and supplements CDMO market size was estimated at USD 48.18 billion in 2025 and is predicted to increase from USD 52.84 billion in 2026 to approximately USD 121.38 billion by 2035, expanding at a CAGR of 9.68% from 2026 to 2035. Massive growth in the ageing population, expanding fitness & sports nutrition trends, and product innovations are driving the global market progression. Many emerging nutraceutical startups rely on cost-effective CDMO services, such as well-trained professionals and advanced technologies.
Involvement of a specialized partner that offers end-to-end services, such as formulation, manufacturing, & packaging, primarily for dietary supplement brands, is termed the vitamins, minerals, and supplements CDMO market. These CDMOs allow firms to outsource production, ensuring regulatory compliance, quality control, & expedited market entry. The overall market development is fueled by a rise in preventive healthcare awareness, surging demand for customized nutrition, & the expansion of nutraceutical startups, which require advanced manufacturing capabilities.
In this era, the globe is extensively leveraging AI solutions to assess large volumes of datasets to estimate the optimal mix of ingredients, like probiotics or vitamins, for stability, bioavailability, & effectiveness, which lowers the need for rigorous physical testing. An eventual breakthrough includes process improvements by using AI algorithms to increase yields & minimize waste. Additionally, AI approaches support tracking international regulatory updates, scanning ingredient lists against guidelines & automating documentation for rapid approval.
Promoting Novel Dosage Forms
The worldwide accelerating demand for optional delivery formats over traditional capsules, like gummies, liquids, and functional powders, is pushing CDMOs to invest in innovative manufacturing technologies.
Emphasis on Sustainability & Compliance
Globally rising consumer aim at clean label products is fostering the adoption of eco-friendly packaging & demand for stricter, transparent quality compliance from CDMO partners.
Execution of Encapsulation Technologies
In the future, research activities will spur the implementation of microencapsulation, nanoencapsulation, & liposomal delivery systems to preserve sensitive ingredients & boost absorption.
| Table | Scope |
| Market Size in 2026 | USD 52.84 Billion |
| Projected Market Size in 2035 | USD 121.38 Billion |
| CAGR (2026 - 2035) | 9.68% |
| Leading Region | North America by 35% |
| Key Applications | Multivitamins, Minerals, Probiotics, Sports Nutrition, Functional Nutrition, Immune Health, Healthy Aging, Personalized Nutrition |
| Primary End Users | Nutraceutical Companies, DTC Supplement Brands, Pharmaceutical Companies, Retail Private Labels, Wellness Brands |
| Key Challenges | Regulatory complexity, raw material sourcing volatility, quality compliance requirements, pricing pressure, supply chain disruptions |
| Measurable Values | USD Millions/Units/Volume |
| Market Segmentation | By Service Type, By Dosage Form, By Product Type, By End User, By Region |
| Top Key Players | Catalent, Inc., Lonza Group AG, Aenova Group, Sirio Pharma Co., Ltd., Akums Drugs & Pharmaceuticals Ltd., NutraScience Labs, Robinson Pharma, Inc., Health Wright Products, Inc., Procaps Group (Softigel), Recipharm AB |
| Segment | Share 2025 (%) |
| Product Development | 28% |
| Manufacturing Services | 42% |
| Packaging Services | 12% |
| Regulatory & Compliance Services | 10% |
| Supply Chain & Logistics | 8% |
The Manufacturing Services Segment Led the Market in 2025
In 2025, the manufacturing services segment held a 42% share of the vitamins, minerals, and supplements CDMO market. A key catalyst is the growing demand for robust immune support, wellness products, & tailored nutrition, specifically among geriatric populations. Alongside, many small-sized, web-based brands are developing, which have limitations in in-house manufacturing infrastructure, demanding CDMOs for end-to-end development, testing, & production.
Moreover, the product development segment held the second-largest share of 28% in 2025 and is predicted to expand at a 9.5% CAGR. Massive demand for consumer-friendly, enjoyable solutions, like gummies, softgels, liquid-filled capsules, & single-serve powders, drives the segmental growth. To comply with complex regulatory landscapes & design specialized products, including vegan or probiotic supplements, brands rely on CDMOs.
The packaging services segment captured a 12% share of the vitamins, minerals, and supplements CDMO market. Increasing demand for convenient & sustainable packaging, along with branding variations, is propelling the respective services & premium packaging. The globe is widely demanding child-safe, tamper-evident, & resealable pouches.
Whereas the regulatory & compliance services segment accounted for 10% share in 2025, due to strict global regulations, which force outsourcing requirements. Besides this, consistent product roll-outs also necessitate extensive regulatory support.
| Segment | Share 2025 (%) |
| Tablets | 34% |
| Capsules | 26% |
| Powders | 14% |
| Liquids | 10% |
| Gummies & Chewables | 16% |
The Tablets Segment Dominated the Market in 2025
The tablets segment led with a 34% share of the market in 2025. Dominance is driven by their high stability, long shelf life, & reduced manufacturing expenditure. Especially, coated tablets provide outstanding stability for multiple vitamin & mineral (MVM) formulations. Often, this form enables precise dosing, with robust masking of unpleasant taste, which raises the overall demand & adoption.
The capsules segment held the second-largest share of 26% of the vitamins, minerals, and supplements CDMO market. Capsules offer boosted bioavailability, with escalated consumer preference for their easy swallowing, which fuels the greater demand. Ongoing softgel capsule innovations assist in developing complex formulations.
However, the gummies & chewables segment held 16% share in 2025 and is anticipated to expand at 11.3% CAGR. Globally surging demand for palatable formats, along with a higher need for immune, digestive & metabolic health, resulting in increased demand for specialized gummy formulations. These kinds are majorly favourable for adults, children, & seniors.
The powders segment captured 14% share in 2025, due to the broadening fitness & sports nutrition trends. As well as, this approach enables personalizable dosing, with bulk packaging having minimal spending.
| Segment | Share 2025 (%) |
| Vitamins | 38% |
| Minerals | 22% |
| Dietary Supplements | 40% |
The Dietary Supplements Segment Was Dominant in the Market in 2025
The dietary supplements segment captured 40% share of the market and is estimated to witness rapid growth at a 10.2% CAGR. After COVID-19, the globe is highly focusing on proactive health & wellness, with expanded preventive healthcare awareness, & nutrition significance, which is fueling the demand for affordable & latest supplements. Alongside, rising demand for immunity boosters & tailored dietary products impacts the segmental development.
In 2025, the vitamins segment accounted for a 38% share of the vitamins, minerals, and supplements CDMO market. The worldwide increasing focus on health maintenance, dietary gaps, specific life stages, & chronic fatigue. Particular demand for multivitamins among the ageing population, pregnant women, & other suffering populations, propels the overall demand for diverse vitamins.
The minerals segment held a 22% share in 2025, due to the growing deficiency-related disorders. Also, the globally surging bone & metabolic health awareness, & booming ageing population burden are demanding minerals & their products.
| Segment | Share 2025 (%) |
| Nutraceutical Companies | 36% |
| Pharmaceutical Companies | 24% |
| Direct-to-Consumer (DTC) Brands | 20% |
| Retail & Private Label Brands | 20% |
The Nutraceutical Companies Segment Led the Market in 2025.
In 2025, the nutraceutical companies segment captured a dominant share of 36% of the vitamins, minerals, and supplements CDMO market. Prominent catalysts are expanding geriatric populations, sedentary lifestyles, faster urbanization, and raised disposable income, which demand high-quality, regulated manufacturing. Strengthening innovations in chewables, gummies, effervescent tablets, & mouth-melting strips also fosters these firms' progression.
Whereas the pharmaceutical companies segment held the second-largest share of 24% in 2025. They explore diversification in supplements, with extensive regulatory expertise, which supports the entire outsourcing. Also, these leaders have rigorous distribution networks, which optimise the expansion.
The direct-to-consumer (DTC) brands segment held 20% share in 2025 and is predicted to expand rapidly at a 11.5% CAGR. They offer radical transparency, with hyper-personalization, & greater convenience. Moreover, Care/of, Rootine, and other brands are leveraging AI-enabled online quizzes & data analytics to facilitate tailored supplement packs.
The retail & private label brands segment captured 20% share of the vitamins, minerals, and supplements CDMO market, due to the immersive affordability. Specifically, retailers employ private labels to distinguish themselves, providing unique products unavailable elsewhere.
In 2025, North America dominated with a 35% share of the market, due to the high supplement consumption & the presence of well-established CDMO. Alongside, the emergence of regulatory clarity also fosters the regional advances. Several Canadian CDMOs are broadly implementing AI & 3D printing to evolve custom supplement protocols in the vitamins, minerals, and supplements CDMO market.
For instance,
U.S. Market Trends
The U.S. was a major contributor to the market, due to the significant & huge consumer base, with revolutionary efforts in novelty, & wider healthcare spending. Along with strong acquisitions, the U.S. players are investing in R&D for excellent bioavailability & specialized production.
In the future, the Asia Pacific captured 28% share and is estimated to grow at 10.5% CAGR in the vitamins, minerals, and supplements CDMO market. This will be spurred by a substantial rise in the geriatric demographics, primarily in Japan, China, & South Korea, coupled with accelerating chronic cases. This further raises demand for supplements targeting cognitive, cardiovascular, & joint health. Also, expanding nutraceutical startups are widely dependent on CDMOs for end-to-end development, manufacturing, & regulatory compliance in APAC.
India Market Trends
Nowadays, India is increasingly demanding precision, premium-priced, high-bioavailability supplements, which impels the market expansion. Besides this, numerous Indian brands are emphasizing attractive branding & influencer marketing, which relies completely on CDMOs for manufacturing.
| Ecosystem Segment | Key Participants | Role in Market |
| Ingredient Technology Providers | DSM-Firmenich, Balchem, Kerry Group, Glanbia Nutritionals | Supply active ingredients, premixes, bioavailability technologies |
| Product Manufacturers | Catalent, Lonza, Aenova, Sirio Pharma | Manufacture vitamins, supplements, gummies, softgels, capsules, tablets |
| CDMOs | Catalent, Lonza, Aenova, Sirio Pharma, Akums, NutraScience Labs | End-to-end development, formulation, manufacturing, packaging |
| Packaging Providers | Constantia Flexibles, Amcor, Berry Global | Supplement packaging and labeling solutions |
| Testing & Quality Service Providers | Eurofins Scientific, SGS, Intertek | Stability testing, quality control, compliance services |
| Platform Providers | Sirio Pharma, NutraScience Labs, Makers Nutrition | Turnkey supplement development platforms |
| Research Institutions | NIH Office of Dietary Supplements, Linus Pauling Institute, Wageningen University | Nutrition science and ingredient research |
| End-User Industries | Nutraceuticals, Pharmaceuticals, Wellness, Sports Nutrition, Functional Foods | Commercial users of VMS manufacturing services |
R&D
Formulation & Final Dosage Preparation
Patient Support & Services
| Tier 1 | Tier 2 | Tier 3 | |
| Typical Market Influence | 58% | 27% | 15% |
| Tier 1 | ||||
| Company Name | Headquarters | Country | Why Relevant to This Market | Key Products/Services |
| Catalent, Inc. | Somerset, New Jersey | USA | Leading global CDMO with extensive nutraceutical manufacturing capabilities | Softgels, gummies, tablets, capsules, formulation development |
| Lonza Group AG | Basel | Switzerland | Major health ingredients and supplement manufacturing provider | Capsules, nutraceutical ingredients, dosage technologies |
| Aenova Group | Starnberg, Bavaria | Germany | One of Europe's largest CDMOs serving nutraceutical brands | Vitamins, supplements, tablets, capsules, packaging |
| Tier 2 | ||||
| Company Name | Headquarters | Country | Why Relevant to This Market | Key Products/Services |
| Akums Drugs & Pharmaceuticals Ltd. | New Delhi | India | Major contract manufacturer with growing nutraceutical portfolio | Vitamins, dietary supplements, gummies, tablets |
| NutraScience Labs | Farmingdale, New York | USA | Specialized nutraceutical CDMO serving private-label brands | Capsules, powders, gummies, formulation services |
| Robinson Pharma, Inc. | Santa Ana, California | USA | Well-established dietary supplement manufacturer | Softgels, capsules, tablets, powders |
| Tier 3 | ||||
| Company Name | Headquarters | Country | Why Relevant to This Market | Key Products/Services |
| Makers Nutrition | Hauppauge, New York | USA | Rapidly growing private-label supplement manufacturer | Gummies, capsules, powders, custom formulations |
| Vitaquest International LLC | West Caldwell, New Jersey | USA | Innovation-focused nutraceutical CDMO | Functional supplements, gummies, powders |
| Zeon Lifesciences Ltd. | Noida, Uttar Pradesh | India | Growing Indian nutraceutical manufacturing specialist | Nutraceutical formulations, private-label supplements |
Strengths
Weaknesses
Opportunities
Threats
By Service Type
By Dosage Form
By Product Type
By End User
By Region
Principal Consultant
Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and strategy.
Learn more about Shivani Zoting
Reviewed By
Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.
Learn more about Aditi Shivarkar
+1 804-441-9344
